IRadimed Corporation (IRMD) Stock Overview
Explore IRadimed Corporation’s financial performance, market position, analyst ratings, and future outlook.
IRadimed Corporation (IRMD)
Key Financials
Key Financials
Market Cap
1.2B
P/E Ratio
52.40
EPS (TTM)
$1.83
ROE
0.24%
IRMD Stock Analysis & Investment Overview
Our comprehensive AI-powered analysis of IRadimed Corporation (IRMD) provides investors with deep insights into the stock's performance, growth potential, and market positioning. With a Meyka AI Score of B+, this stock demonstrates moderate investment characteristics based on our advanced machine learning models.
The current technical analysis reveals key indicators including an RSI of 62.79, suggesting the stock is in a neutral condition. Our forecasting models predict significant price movements, with a 12-month target of $120.05.
Key financial metrics showcase the company's fundamental strength, including a P/E ratio of 52.40 and a market capitalization of 1.2B. These metrics, combined with our AI analysis, provide a comprehensive view for both institutional and retail investors.